 |
| Cyclo-RGDfK |
| Product | cRGDfK |
| Sequence |
Cyclo(Arg-Gly-Asp-D-Phe-Lys)
|
| CAS# | 161552-03-0 |
| MDL | MFCD00937400 |
| Formula | C27H41N9O7 |
| M.W. | 603.7 |
| Appearance | White to off-white lyophilised powder |
| Purity | ≥90%, ≥95%, ≥98% |
| Solubility | H2O |
| Packaging | 1mg, 5mg, 25mg, 100mg, 250mg, 1g... or pack on request |
| Storage | Kept under -20o or lower |
| Price | Request A Quote |
| Use | For the research and development purpose only |
| Cited in | Yang, et al. (2014), RGD-Conjugated Nanoscale Coordination Polymers for Targeted T1- and T2-weighted Magnetic Resonance Imaging of Tumors in Vivo. Adv. Funct. Mater., 24: 1738–1747. Zhang, et al. (2012). Transferrin-Modified c[RGDfK]-Paclitaxel Loaded Hybrid Micelle for Sequential Blood-Brain Barrier Penetration and Glioma Targeting Therapy. Mol. Pharmaceutics. 9:1590–1598. Xu, et al. (2012) RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin. International Journal of Nanomedcine. 7: 211 - 219. |
No comments:
Post a Comment